Vitamin D receptor ligands: the impact of crystal structures

Bibliography

• DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004;80:1689S-96S
   PubMed Web of Science ®Google Scholar
• Institute-of-Medicine. Dietary Reference Intakes for Calcium and Vitamin D. National Academies Press; Washington, DC: 2010
   Google Scholar
• Heaney RP, Holick MF. Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res 2011;26:455-7
   PubMed Web of Science ®Google Scholar
• Renkema KY, Alexander RT, Bindels RJ, Calcium and phosphate homeostasis: concerted interplay of new regulators. Ann Med 2008;40:82-91
   PubMed Web of Science ®Google Scholar
• Verstuyf A, Carmeliet G, Bouillon R, Vitamin D: a pleiotropic hormone. Kidney Int 2010;78:140-5
   PubMed Web of Science ®Google Scholar
• Bouillon R, Okamura WH, Norman AW. Structure-function relationships in the vitamin D endocrine system. Endocr Rev 1995;16:200-57
   PubMed Web of Science ®Google Scholar
• Carlberg C. Molecular basis of the selective activity of vitamin D analogues. J Cell Biochem 2003;88:274-81
   PubMed Web of Science ®Google Scholar
• Norman AW. Receptors for 1alpha,25(OH)2D3: past, present, and future. J Bone Mineral Res 1998;13:1360-9
   PubMed Web of Science ®Google Scholar
• Evans RM. The steroid and thyroid hormone receptor superfamily. Science 1988;240:889-95
   PubMed Web of Science ®Google Scholar
• Carlberg C. Mechanisms of nuclear signalling by vitamin D3. Interplay with retinoid and thyroid hormone signalling. Eur J Biochem 1995;231:517-27
   PubMedGoogle Scholar
• Carlberg C, Molnar F. Detailed molecular understanding of agonistic and antagonistic vitamin D receptor ligands. Curr Top Med Chem 2006;6:1243-53
   PubMed Web of Science ®Google Scholar
• Carlberg C, Mourino A. New vitamin D receptor ligands. Expert Opin Ther Patents 2003;13:761-72
   Web of Science ®Google Scholar
• Carlberg C, Molnar F. Current status of vitamin D signaling and its therapeutic applications. Curr Top Med Chem 2012; In press
   Google Scholar
• Rochel N, Moras D. Structural Basis for Ligand Activity in VDR. In: Feldman D, Pike JW, Adams JS, editors. Vitamin D. 3rd edition. Academic Press Amsterdam; 2011. 171-92
   Google Scholar
• Rochel N, Wurtz JM, Mitschler A, Crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol Cell 2000;5:173-9
   PubMed Web of Science ®Google Scholar
• Tocchini-Valentini G, Rochel N, Wurtz JM, Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands. Proc Natl Acad Sci USA 2001;98:5491-6
   PubMed Web of Science ®Google Scholar
• Tocchini-Valentini G, Rochel N, Wurtz JM, Crystal structures of the vitamin D nuclear receptor liganded with the vitamin D side chain analogues calcipotriol and seocalcitol, receptor agonists of clinical importance. Insights into a structural basis for the switching of calcipotriol to a receptor antagonist by further side chain modification. J Med Chem 2004;47:1956-61
   PubMed Web of Science ®Google Scholar
• Eelen G, Valle N, Sato Y, Superagonistic fluorinated vitamin D3 analogs stabilize helix 12 of the vitamin D receptor. Chem Biol 2008;15:383-92
   Google Scholar
• Vanhooke JL, Benning MM, Bauer CB, Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide. Biochemistry 2004;43:4101-10
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Abe D, Yoshimoto N, Vitamin D receptor: ligand recognition and allosteric network. J Med Chem 2006;49:1313-24
   Google Scholar
• Sussman F, Rumbo A, Villaverde MC, Predicting the cell differentiation activity of 1alpha,25-dihydroxyvitamin D3 side chain analogues from docking simulations. J Med Chem 2004;47:1613-16
   Google Scholar
• Hourai S, Rodrigues L, Antony P, Structure-based design of a superagonist ligand for the vitamin D nuclear receptor. Chem Biol. Academic Press; Amsterdam: 2008;15:383-92
   Google Scholar
• Antony P, Sigueiro R, Huet T, Structure-function relationships and crystal structures of the vitamin D receptor bound 2alpha-methyl-(20S,23S)- and 2alpha-methyl-(20S,23R)-epoxymethano-1alpha,25-dihydroxyvitamin D3. J Med Chem 2010;53:1159-71
   Google Scholar
• Moras D, Mourino-Mosquera A, Rodrigues LC, Preparation of vitamin D derivatives as vitamin D receptor agonists. WO2007039526; 2007
   Google Scholar
• Perez-Garcia X, Rumbo A, Larriba MJ, The first locked side-chain analogues of calcitriol (1alpha,25-dihydroxyvitamin D3) induce vitamin D receptor transcriptional activity. Org Lett 2003;5:4033-6
   Google Scholar
• Rochel N, Hourai S, Perez-Garcia X, Crystal structure of the vitamin D nuclear receptor ligand binding domain in complex with a locked side chain analog of calcitriol. Arch Biochem Biophys 2007;460:172-6
   PubMedGoogle Scholar
• Gonzalez-Avion XC, Mourino A, Rochel N, Novel 1alpha,25-dihydroxyvitamin D3 analogues with the side chain at C12. J Med Chem 2006;49:1509-16
   Google Scholar
• Verlinden L, Verstuyf A, Eelen G, Synthesis, structure, and biological activity of des-side chain analogues of 1alpha,25-dihydroxyvitamin D3 with substituents at C18. ChemMedChem 2011;6:788-93
   Google Scholar
• Eelen G, Verlinden L, Bouillon R, CD-ring modified vitamin D3 analogs and their superagonistic action. J Steroid Biochem Mol Biol 2010;121:417-19
   PubMedGoogle Scholar
• Tavera-Mendoza L, Wang TT, Lallemant B, Convergence of vitamin D and retinoic acid signalling at a common hormone response element. EMBO Rep 2006;7:180-5
   Google Scholar
• White JH, Gleason JL, Tavera-Mendoza L, Preparation of hybrid molecules having mixed vitamin D receptor agonism and histone deacetylase inhibitory properties. WO2007 131364;2007
   Google Scholar
• Glebocka A, Sicinski RR, Plum LA, Synthesis and biological activity of 2-(3'-hydroxypropylidene)-1alpha-hydroxy-19-norvitamin D analogues with shortened alkyl side chains. J Med Chem 2011;54:6832-42
   Google Scholar
• DeLuca HF, Glebocka A, Sokolowska K, 19-Nor-vitamin D analogs with 3,2-dihydrofuran ring. US20107648974; 2010
   Google Scholar
• DeLuca HF, Glebocka A, Sokolowska K, 19-Nor-vitamin D analogs with 1,2-dihydrofuran ring. US20117879829; 2011
   Google Scholar
• Kubodera N, Tsuji N, Uchiyama Y, A new active vitamin D analog, ED-71, causes increase in bone mass with preferential effects on bone in osteoporotic patients. J Cell Biochem 2003;88:286-9
   Google Scholar
• Tsuji N, Takahashi A. Agent for preventing non-traumatic vertebral fracture in severe osteoporotic patients which comprises eldecalcitol. WO2010126094; 2010
   Google Scholar
• Katsuki H, Shibata A, Muramatsu K, ED-71 preparation having improved storage stability. WO2005074943; 2005
   Google Scholar
• Malloy PJ, Feldman D. Vitamin D resistance. Am J Med 1999;106:355-70
   Google Scholar
• Kittaka A, Saito N, Honzawa S, Creative synthesis of novel vitamin D analogs for health and disease. J Steroid Biochem Mol Biol 2007;103:269-76
   Google Scholar
• Takayama H, Fujishima T, Suhara Y, Preparation of vitamin D derivatives having substituents at the 2alpha-position. WO2001016099; 2001
   Google Scholar
• Molnar F, Sigueiro R, Sato Y, 1alpha,25(OH)2-3-epi-vitamin D3, a natural physiological metabolite of vitamin D3: its synthesis, biological activity and crystal structure with its receptor. PLoS One 2011;6:e18124
   PubMed Web of Science ®Google Scholar
• DeLuca HF, Plum LA, Clagett-Dame M. Selective analogs of 1alpha,25-dihydroxyvitamin D3 for the study of specific functions of vitamin D. J Steroid Biochem Mol Biol 2007;103:263-8
   Google Scholar
• DeLuca HF, Głebocka A, Sicinski RR, 1alpha-Hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin D compounds with a 1,1-dimethylpropyl side chain. US20107763598; 2010
   Google Scholar
• DeLuca HF, Sicinski RR, Plum LA, 1alpha-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin D compounds and methods of making and treatment thereof. US20118058265; 2011
   Google Scholar
• Posner GH, Jeon HB, Sarjeant A, Low-calcemic, efficacious 1alpha,25-dihydroxyvitamin D3 analog QW-1624F2-2: calcemic dose-response determination, preclinical genotoxicity testing, and revision of A-ring stereochemistry. Steroids 2004;69:757-62
   PubMedGoogle Scholar
• Dixon KM, Deo SS, Wong G, Skin cancer prevention: a possible role of 1,25-dihydroxyvitamin D3 and its analogs. J Steroid Biochem Mol Biol 2005;97:137-43
   PubMed Web of Science ®Google Scholar
• Reddy CD, Patti R, Guttapalli A, Anticancer effects of the novel 1alpha,25-dihydroxyvitamin D3 hybrid analog QW1624F2-2 in human neuroblastoma. J Cell Biochem 2006;97:198-206
   PubMedGoogle Scholar
• Peleg S, Petersen KS, Suh BC, Low-calcemic, highly antiproliferative, 1-difluoromethyl hybrid analogs of the natural hormone 1alpha,25-dihydroxyvitamin D3: design, synthesis, and preliminary biological evaluation. J Med Chem 2006;49:7513-17
   Google Scholar
• De Clercq PJ, De Buysser F, Minne G, The development of CD-ring modified analogs of 1alpha,25-dihydroxyvitamin D. J Steroid Biochem Mol Biol 2007;103:206-12
   Google Scholar
• Mouton J, Pellegrino F, Lafay J. New process for isomerizing fused bicyclic structures and preparation of vitamin D analogs comprising the same. US20110184198; 2011
   Google Scholar
• Delansorne D, Dufour-Lamartine J. New therapeutical uses of inecalcitol. WO2010145903; 2010
   Google Scholar
• Chen YJ, Gao LJ, Murad I, Synthesis, biological activity, and conformational analysis of CD-ring modified trans-decalin 1alpha,25-dihydroxyvitamin D analogs. Org Biomol Chem 2003;1:257-67
   Google Scholar
• Verlinden L, Verstuyf A, Verboven C, Previtamin D3 with a trans-fused decalin CD-ring has pronounced genomic activity. J Biol Chem 2003;278:35476-82
   Google Scholar
• Wu Y, De Clercq P, Vandewalle M, Vitamin D3: synthesis of seco-C-9,11-bisnor-17-methyl-1alpha,25-dihydroxyvitamin D3 analogues. Bioorg Med Chem Lett 2002;12:1633-6
   Google Scholar
• Plonska-Ocypa K, Grzywacz P, Sicinski R, Synthesis and biological evaluation of a des-C,D-analog of 2-methylene-19-nor-1alpha,25-(OH)2D3. J Steroid Biochem Mol Biol 2007;103:298-304
   PubMedGoogle Scholar
• DeLuca HF, Plonska-Ocypa K, Sicinski R, Des-C,D analogs of 1alpha,25-dihydroxy-19-norvitamin D3. US20097534777; 2009
   Google Scholar
• Barycki R, Sicinski RR, Plum LA, Removal of the 20-methyl group from 2-methylene-19-nor-(20S)-1alpha,25-dihydroxyvitamin D3 (2MD) selectively eliminates bone calcium mobilization activity. Bioorg Med Chem 2009;17:7658-69
   Google Scholar
• DeLuca HF, Barycki R, Grzywacz P, 2-Alkylidene-18,19-dinor-vitamin D compounds. US20107713951; 2010
   Google Scholar
• Takano M, Sawada D, Kittaka A, 15-substituted vitamin D3 derivatives. JP2009191032; 2009
   Google Scholar
• Shindo K, Kumagai G, Takano M, New C15-substituted active vitamin D3. Org Lett 2011;13:2852-5
   Google Scholar
• Sokolowska K, Mourino A, Sicinski RR, Synthesis and biological evaluation of 6-methyl analog of 1alpha,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol 2010;121:29-33
   Google Scholar
• Clagett-Dame M, DeLuca HF, Mourino A, 6-Methylvitamin D3 analogs and their uses. WO201141599; 2011
   Google Scholar
• Sawada D, Kittaka A. Preparation of 14-epi-19-norprevitamin D3 derivatives, antiosteoporotic agents containing them, and their intermediates. JP2010111593; 2010
   Google Scholar
• Sawada D, Tsukuda Y, Saito H, Development of 14-epi-19-nortachysterol and its unprecedented binding configuration for the human vitamin D receptor. J Am Chem Soc 2011;133:7215-21
   PubMed Web of Science ®Google Scholar
• Toell A, Gonzalez MM, Ruf D, Different molecular mechanisms of vitamin D3 receptor antagonists. Mol Pharmacol 2001;59:1478-85
   Google Scholar
• Herdick M, Steinmeyer A, Carlberg C. Antagonistic action of a 25-carboxylic ester analogue of 1alpha,25-dihydroxyvitamin D3 is mediated by a lack of ligand-induced vitamin D receptor interaction with coactivators. J Biol Chem 2000;275:16506-12
   Google Scholar
• Bury Y, Steinmeyer A, Carlberg C. Structure activity relationship of carboxylic ester antagonists of the vitamin D3 receptor. Mol Pharmacol 2000;58:1067-74
   PubMed Web of Science ®Google Scholar
• Miura D, Manabe K, Gao Q, 1alpha,25-dihydroxyvitamin D3-26,23-lactone analogues antagonize differentiation of human leukemia cells (HL-60 cells) but not of human acute promyelocytic leukemia cells (NB4 cells). FEBS Lett 1999;460:297-302
   Google Scholar
• Miura D, Manabe K, Ozono K, Antagonistic action of novel 1alpha,25-dihydroxyvitamin D3-26,23-lactone analogs on differentiation of human leukemia cells (HL-60) induced by 1alpha,25-dihydroxyvitamin D3. J Biol Chem 1999;274:16392-9
   Google Scholar
• Ozono K, Saiti M, Miura D, Analysis of the molecular mechanism for the antagonistic action of a novel 1alpha,25-dihydroxyvitamin D3 analogue toward vitamin D receptor function. J Biol Chem 1999;274:32376-81
   Google Scholar
• Vaisanen S, Perakyla M, Karkkainen JI, Critical role of helix 12 of the vitamin D3 receptor for the partial agonism of carboxylic ester antagonists. J Mol Biol 2002;315:229-38
   Google Scholar
• Bula CM, Bishop JE, Ishizuka S, 25-Dehydro-1alpha-hydroxyvitamin D3-26,23S-lactone antagonizes the nuclear vitamin D receptor by mediating a unique noncovalent conformational change. Mol Endocrinol 2000;14:1788-96
   PubMedGoogle Scholar
• Saito N, Saito H, Anzai M, Dramatic enhancement of antagonistic activity on vitamin D receptor: a double functionalization of 1alpha-hydroxyvitamin D3 26,23-lactones. Org Lett 2003;5:4859-62
   Google Scholar
• Fujishima T, Kittaka A, Yamaoka K, Synthesis of 2,2-dimethyl-1,25-dihydroxyvitamin D3: A-ring structural motif that modulates interactions of vitamin D receptor with transcriptional coactivators. Org Biomol Chem 2003;1:1863-9
   Google Scholar
• Kakuda S, Ishizuka S, Eguchi H, Structural basis of the histidine-mediated vitamin D receptor agonistic and antagonistic mechanisms of (23S)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone. Acta Crystallogr D Biol Crystallogr 2010;66:918-26
   Google Scholar
• Perakyla M, Molnar F, Carlberg C. A structural basis for the species-specific antagonism of 26,23-lactones on vitamin D signaling. Chem Biol 2004;11:1147-56
   Google Scholar
• Lamblin M, Spingarn R, Wang TT, An o-aminoanilide analogue of 1alpha,25-dihydroxyvitamin D3 functions as a strong vitamin D receptor antagonist. J Med Chem 2010;53:7461-5
   Google Scholar
• Igarashi M, Yoshimoto N, Yamamoto K, Identification of a highly potent vitamin D receptor antagonist: (25S)-26-adamantyl-25-hydroxy-2-methylene-22,23-didehydro-19,27-dinor-20-epi-vitamin D3 (ADMI3). Arch Biochem Biophys 2007;460:240-53
   Google Scholar
• Nakabayashi M, Yamada S, Yoshimoto N, Crystal structures of rat vitamin D receptor bound to adamantyl vitamin D analogs: structural basis for vitamin D receptor antagonism and partial agonism. J Med Chem 2008;11:5320-9
   Google Scholar
• Inaba Y, Yoshimoto N, Sakamaki Y, A new class of vitamin D analogues that induce structural rearrangement of the ligand-binding pocket of the receptor. J Med Chem 2009;12:1438-49
   Google Scholar
• Yamamoto K, Inaba Y, Yoshimoto N, 22-Alkyl-20-epi-1alpha,25-dihydroxyvitamin D3 compounds of superagonistic activity: syntheses, biological activities and interaction with the receptor. J Med Chem 2007;50:932-9
   Google Scholar
• Inaba Y, Nakabayashi M, Itoh T, 22S-butyl-1alpha,24R-dihydroxyvitamin D3: recovery of vitamin D receptor agonistic activity. J Steroid Biochem Mol Biol 2010;121:146-50
   Google Scholar
• Nakano Y, Kato Y, Imai K, Practical synthesis and evaluation of the biological activities of 1alpha,25-dihydroxyvitamin D3 antagonists, 1alpha,25-dihydroxyvitamin D3-26,23-lactams. Designed on the basis of the helix 12-folding inhibition hypothesis. J Med Chem 2006;49:2398-406
   Google Scholar
• Herdick M, Bury Y, Quack M, Response element- and coactivator-mediated conformational change of the vitamin D3 receptor permits sensitive interaction with agonists. Mol Pharmacol 2000;57:1206-17
   PubMed Web of Science ®Google Scholar
• Vaisanen S, Perakyla M, Karkkainen JI, Structural evaluation of a vitamin D analogue with two side chains. Mol Pharmacol 2003;63:1230-7
   Google Scholar
• Maehr H, Uskokovic M, Adorini L, Calcitriol derivatives with two different side chains at C-20 III. An epimeric pair of the Gemini family with unprecedented antiproliferative effects on tumor cells and renin mRNA expression inhibition. J Steroid Biochem Mol Biol 2007;103:277-81
   Google Scholar
• Adorini L, Penna G, Uskokovic M, Preparation of Gemini vitamin D3 compounds and methods of use thereof. 2008.US20080280859
   Google Scholar
• Jankowski P, Uskokovic M, Adorini L. Preparation of 20-alkyl Gemini vitamin D3 compounds for therapeutic use. WO2006102647; 2006
   Google Scholar
• Adorini L, Pena G, Uskokovic M, Preparation and formulation of Gemini vitamin D3 compounds for the treatment of vitamin D3 associated states. WO2004098522; 2004
   Google Scholar
• Verstuyf A, Verlinden L, van Baelen H, The biological activity of nonsteroidal vitamin D hormone analogs lacking both the C- and D-rings. J Bone Miner Res 1998;13:549-58
   PubMed Web of Science ®Google Scholar
• Norman AW, Manchand PS, Uskokovic MR, Characterization of a novel analog of 1〈,25(OH)2-vitamin D3 with two side chains: interaction with its nuclear receptor and cellular actions. J Med Chem 2000;43:2719-30
   PubMed Web of Science ®Google Scholar
• Yin D, He Y, Perera MA, Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor. Mol Pharmacol 2003;63:211-23
   PubMed Web of Science ®Google Scholar
• Fink BE, Mortensen DS, Stauffer SR, Novel structural templates for estrogen-receptor ligands and prospects for combinatorial synthesis of estrogens. Chem Biol 1999;6:205-19
   PubMed Web of Science ®Google Scholar
• Allegretto EA, Boehm MF, Nadzan AM. Vitamin D3 mimics. WO200010958; 2000
   Google Scholar
• Boehm MF, Fitzgerald P, Zou A, Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3. Chem Biol 1999;6:265-75
   PubMed Web of Science ®Google Scholar
• Swann SL, Bergh J, Farach-Carson MC, Structure-based design of selective agonists for a rickets-associated mutant of the vitamin D receptor. J Am Chem Soc 2002;124:13795-805
   PubMed Web of Science ®Google Scholar
• Swann SL, Bergh JJ, Farach-Carson MC, Rational design of vitamin D3 analogues which selectively restore activity to a vitamin D receptor mutant associated with rickets. Org Lett 2002;4:3863-6
   Google Scholar
• Perakyla M, Malinen M, Herzig KH, Gene regulatory potential of nonsteroidal vitamin D receptor ligands. Mol Endocrinol 2005;19:2060-73
   PubMedGoogle Scholar
• Kakuda S, Okada K, Eguchi H, Structure of the ligand-binding domain of rat VDR in complex with the nonsecosteroidal vitamin D3 analogue YR301. Acta Crystallogr Sect F Struct Biol Cryst Commun 2008;64:970-3
   Google Scholar
• Gajewski R, Jones C, Lu J, Phenyl-furan compounds as vitamin D receptor modulators. WO2005051936; 2005
   Google Scholar
• Fujii S, Masuno H, Taoda Y, Boron cluster-based development of potent nonsecosteroidal vitamin D receptor ligands: direct observation of hydrophobic interaction between protein surface and carborane. J Am Chem Soc 2011;133:20933-41
   PubMed Web of Science ®Google Scholar
• Kabat MM, Radinov R. The practical synthesis of vitamin D analogs: a challenge for process research. Curr Opin Drug Discov Devel 2001;4:808-33
   PubMedGoogle Scholar
• Bouillon R, Allewaert K, van Leeuwen JPTM, Structure function analysis of vitamin D analogs with C-ring modifications. J Biol Chem 1992;267:3044-51
   Google Scholar
• Trost BM, Dumas J, Villa M. New strategies for the synthesis of vitamin D metabolites via Pd-catalyzed reactions. J Am Chem Soc 1992;114:9836-45
   Web of Science ®Google Scholar
• Saito N, Matsunaga T, Saito H, Further synthetic and biological studies on vitamin D hormone antagonists based on C24-alkylation and C2alpha-functionalization of 25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactones. J Med Chem 2006;49:7063-75
   Google Scholar
• Pranjal G, Sigueiro R, Eduardo S, An expeditious route to 1alpha,25-dihydroxyvitamin D3 analogs via aqueous tandem palladium catalyzed A-ring closure and Suzuki coupling with C/D unit. Chem Eur J 2010;16:1432-5
   Google Scholar
• Sicinski RR, Glebocka A, Plum LA, Design, synthesis, and biological evaluation of a 1alpha,25-dihydroxy-19-norvitamin D3 analogue with a frozen A-ring conformation. J Med Chem 2007;50:6154-64
   Google Scholar
• Glebocka A, Sicinski RR, Plum LA, New 2-alkylidene 1alpha,25-dihydroxy-19-norvitamin D3 analogues of high intestinal activity: synthesis and biological evaluation of 2-(3'-alkoxypropylidene) and 2-(3'-hydroxypropylidene) derivatives. J Med Chem 2006;49:2909-20
   Google Scholar
• Ono K, Yoshida A, Saito N, Efficient synthesis of 2-modified 1alpha,25-dihydroxy-19-norvitamin D3 with Julia olefination: high potency in induction of differentiation on HL-60 cells. J Org Chem 2003;68:7407-15
   PubMed Web of Science ®Google Scholar